🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a multicenter, open label, randomized phase II study to evaluate t...
Status
Terminated
Location
Cedars Sinai Medical Center SC-3
Start Date
2012-10
Trial ID
NCT01628913
Treatments Being Tested
To estimate the difference in efficacy and safety of bevacizumab and RAD001...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2008-11-12
Trial ID
NCT00719264
Treatments Being Tested
This Phase III, randomized, open-label, multicenter study will evaluate the...
Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Start Date
2022-08-03
Trial ID
NCT05306340
Treatments Being Tested
Primary objectives: A. To evaluate the effect of Zortress® versus standard ...
Status
Withdrawn
Location
University of Kentucky
Start Date
2012-05
Trial ID
NCT01612299
Treatments Being Tested
This is a single-arm, multicenter, Phase 2 study of lenvatinib in combinati...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2017-02-20
Trial ID
NCT02915783
Treatments Being Tested
Endometrial cancer is the most common malignancy of the female reproductive...
Status
Completed
Location
Yale University School of Medicine
Start Date
2008-12
Trial ID
NCT00703807
This study is a single-arm, phase II study of everolimus in patients with P...
Status
Completed
Location
Samsung Medical center
Start Date
2015-02
Trial ID
NCT02449538
Treatments Being Tested
To evaluate the benefit of a precision medicine based strategy (targeted th...
Status
Not Yet Recruiting
Location
University Hospital Brno
Start Date
2026-09-01
Trial ID
NCT07522801
Treatments Being Tested
Study I3G-MC-JGCB (JGCB) is a multicenter, nonrandomized, open-label, dose-...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-03
Trial ID
NCT01115803
Treatments Being Tested
LEVEL trial aims to demonstrate the higher efficacy of 177Lu-edotreotide ov...
Status
Recruiting
Location
Antwerp University Hospital (UZA)
Start Date
2023-10-27
Trial ID
NCT05918302
Treatments Being Tested